ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 619196 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 619196; 2) Community: the network communities that were significantly associated with the response to NSC 619196; 3) Molecule: the relationships between components within communities and NSC 619196; 4) MDR: the compounds that were significantly associated with the NSC 619196.

NSC Compound Enrichment Correlation
NSC 356777 2-Propen-1-one, 3-(4-chlorophenyl)-1-(1-hydroxy-7-oxo- 1,3,5-cycloheptriene-2-yl)- 0.0352028253287042 0.081365442
NSC 372950 Null 0.0352028253287042 0.23815933
NSC 381866 BAFILOMYCIN DERIV. 0.0352028253287042 0.33771377
NSC 382770 Null 0.0352028253287042 0.11813797
NSC 56902 Null 0.0352028253287042 0.20413806
NSC 606698 Rapamycin prodrug, Mono-(28)-N,N-dimethylglycinate-, methanesulfonic acid salt 0.0352028253287042 -0.063254791
NSC 747651 2-CHLORO-1-NITROSOPYRIDO[3',2':4,5]PYRROLO[1,2-C]BENZOTRIAZINE 0.0352028253287043 0.26290207
NSC 625350 Benzenepropanoic acid, .beta.-(benzoylamino)-.alpha.- hydroxy-, (9,10-dihydro-9,10-dioxo-2-anthracenyl)methyl ester (R*,R*) 0.0366216145653011 -0.10660002
NSC 113908 Null 0.0392716453377535 0.10374469
NSC 163062 TRIPTOLIDE 0.0392716453377535 0.23735214
Total:50  Current:37    [First] [Prev] [Next] [Last]